KKR India Said Buying 30%, Stake In Southeast Asian Gland Pharma
This article was originally published in PharmAsia News
Executive Summary
KKR is making another investment raid on a Southeast Asia drug maker, this time paying $150 million for a 30% stake in Gland Pharma, according to sources.